Literature DB >> 497645

Bilio-pancreatic bypass for obesity: II. Initial experience in man.

N Scopinaro, E Gianetta, D Civalleri, U Bonalumi, V Bachi.   

Abstract

After a successful trial of bilio-pancreatic bypass in dogs, a clinical study has been completed in 18 patients followed for more than 1 year. The operation has been modified to achieve the best weight reduction, and forming the bilio-pancreatic tract of equal length to the alimentary tract with a short common ileal tract, the average weight loss as a percentage of the preoperative body weight was 24.1 +/- 5.4 per cent (mean +/- s.d.) at 6 months and 33.7 +/- 4.1 per cent at 12 months. The only immediate complication was a wound dehiscence, and there were no late complications. Liver function studies showed the absence of hepatic deterioration and liver biopsies showed improvement of liver morphology 1 year after the operation. It is suggested that this procedure may be an alternative to jejuno-ileal bypass in the management of obesity.

Entities:  

Mesh:

Year:  1979        PMID: 497645     DOI: 10.1002/bjs.1800660906

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  97 in total

1.  Implantable gastric stimulation (IGS) as therapy for human morbid obesity: report from the 2001 IFSO symposium in Crete.

Authors:  Robert J Greenstein; Mitiku Belachew
Journal:  Obes Surg       Date:  2002-04       Impact factor: 4.129

2.  Laparoscopic vs. open biliopancreatic diversion with duodenal switch: a comparative study.

Authors:  Won-Woo Kim; Michel Gagner; Subhash Kini; William B Inabnet; Terri Quinn; Daniel Herron; Alfons Pomp
Journal:  J Gastrointest Surg       Date:  2003 May-Jun       Impact factor: 3.452

3.  Indications, safety, and feasibility of conversion of failed bariatric surgery to Roux-en-Y gastric bypass: a retrospective comparative study with primary laparoscopic Roux-en-Y gastric bypass.

Authors:  Bert Deylgat; Mathieu D'Hondt; Hans Pottel; Franky Vansteenkiste; Frank Van Rooy; Dirk Devriendt
Journal:  Surg Endosc       Date:  2012-01-19       Impact factor: 4.584

Review 4.  [Metabolic surgery].

Authors:  C Jurowich; C T Germer; F Seyfried; A Thalheimer
Journal:  Chirurg       Date:  2012-06       Impact factor: 0.955

5.  Long-term results of biliopancreatic diversion with or without gastric preservation for morbid obesity.

Authors:  Nicola Crea; Giacomo Pata; Ernesto Di Betta; Francesco Greco; Claudio Casella; Antonio Vilardi; Francesco Mittempergher
Journal:  Obes Surg       Date:  2011-02       Impact factor: 4.129

Review 6.  Metabolic surgery for the treatment of type 2 diabetes in patients with BMI <35 kg/m2: an integrative review of early studies.

Authors:  M Fried; G Ribaric; J N Buchwald; S Svacina; K Dolezalova; N Scopinaro
Journal:  Obes Surg       Date:  2010-06       Impact factor: 4.129

7.  MGB-OAGB: Effect of Biliopancreatic Limb Length on Nutritional Deficiency, Weight Loss, and Comorbidity Resolution.

Authors:  Anmol Ahuja; Om Tantia; Ghanshyam Goyal; Tamonas Chaudhuri; Shashi Khanna; Anshuman Poddar; Sonam Gupta; Kajari Majumdar
Journal:  Obes Surg       Date:  2018-11       Impact factor: 4.129

Review 8.  Biliopancreatic diversion in the surgical treatment of morbid obesity.

Authors:  Robrecht H G G Van Hee
Journal:  World J Surg       Date:  2004-04-19       Impact factor: 3.352

9.  Short-, mid- and long-term results of Larrad biliopancreatic diversion.

Authors:  Alvaro Larrad-Jiménez; Carlos Sánchez-Cabezudo Díaz-Guerra; Pedro de Cuadros Borrajo; Irene Bretón Lesmes; Basilio Moreno Esteban
Journal:  Obes Surg       Date:  2007-02       Impact factor: 4.129

10.  Twenty-four hour insulin secretion and beta cell NEFA oxidation in type 2 diabetic, morbidly obese patients before and after bariatric surgery.

Authors:  S Salinari; A Bertuzzi; A Iaconelli; M Manco; G Mingrone
Journal:  Diabetologia       Date:  2008-05-06       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.